Research Article
A retrospective survey of perinatal risk factors of 104 living children with holoprosencephaly
Article first published online: 23 MAR 2004
DOI: 10.1002/ajmg.a.30070
Copyright © 2004 Wiley-Liss, Inc.
Additional Information
How to Cite
Stashinko, E. E., Clegg, N. J., Kammann, H. A., Sweet, V. T., Delgado, M. R., Hahn, J. S. and Levey, E. B. (2004), A retrospective survey of perinatal risk factors of 104 living children with holoprosencephaly. American Journal of Medical Genetics Part A, 128A: 114–119. doi: 10.1002/ajmg.a.30070
Publication History
- Issue published online: 17 JUN 2004
- Article first published online: 23 MAR 2004
- Manuscript Accepted: 20 OCT 2003
- Manuscript Received: 14 FEB 2003
Funded by
- Carter Centers for Brain Research in Holoprosencephaly and Related Malformations
- Don and Linda Carter Foundation
- Abstract
- Article
- References
- Cited By
Keywords:
- holoprosencephaly;
- risk factors;
- prenatal diagnosis
Abstract
Holoprosencephaly (HPE) is a brain malformation resulting from a primary defect in development of the basal forebrain during early gestation. Prenatal genetic and environmental factors and birth outcomes were described in a population of 104 children with holoprosencephaly referred to three clinical centers from 1998 through 2002. The mean child age was 4 years. Of cases karyotyped, 9% presented with a chromosomal abnormality. This study of living children with holoprosencephaly, the majority of whom are cytogenetically normal, provides new information on the subsample of children with a less severe phenotype. Most children were born at term; about 51% were microcephalic at birth. Consistent with previous research, the association between HPE and maternal history of diabetes merits further investigation. Several findings have important implications for future research. Only 22% of the children in this study sample were diagnosed with holoprosencephaly prenatally. The vast majority of children (72%) were diagnosed with HPE between birth and 1 year of age. Also, 19% of the cases referred to the Carter Centers with HPE were not confirmed on scan review. When possible, future population-based epidemiological studies should emphasize mechanisms that identify children with HPE outside of the newborn period and confirm the diagnosis by review of MRI or high quality CT brain scan. © 2004 Wiley-Liss, Inc.

1552-4833/asset/olbannerleft.gif?v=1&s=dc5513758e0602016bfe88cd52afd78bf862aab9)
1552-4833/asset/olbannerright.gif?v=1&s=c3d8a0f0a45667625907578ec1e0f011cbe060b1)
1552-4833/asset/cover.gif?v=1&s=9818ec8c89d0772bf0e752b15694c460afb83f9f)